MSInsight Revenue and Competitors
Estimated Revenue & Valuation
- MSInsight's estimated annual revenue is currently $2.3M per year.
- MSInsight's estimated revenue per employee is $230,400
Employee Data
- MSInsight has 10 Employees.
- MSInsight grew their employee count by 43% last year.
MSInsight's People
| Name | Title | Email/Phone |
|---|
MSInsight Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $37.4M | 98 | 20% | N/A | N/A |
#2 | $25.6M | 67 | 22% | N/A | N/A |
#3 | $232.8M | 489 | 24% | N/A | N/A |
#4 | $7.9M | 26 | 100% | $17.1M | N/A |
#5 | $102.8M | 245 | 23% | N/A | N/A |
#6 | $43.8M | 115 | 22% | N/A | N/A |
#7 | $39.7M | 104 | 22% | N/A | N/A |
#8 | $1.9M | 8 | 60% | N/A | N/A |
#9 | $3.3M | 14 | 17% | N/A | N/A |
#10 | $60.9M | 145 | 22% | N/A | N/A |
What Is MSInsight?
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. \n\nMSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. \n\nWe aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$2.3M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.9M | 10 | -17% | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $0.9M | 10 | N/A | N/A |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $0.9M | 10 | N/A | N/A |